Companies

See how salaries can vary from company to company

Started with a single vehicle in 2005, Immaculate Flight continues to proudly serve the global aviation community as a leader in aircraft cleaning and detailing services with present-day locations in 13 states and 115+ airports around the US. We are proud to offer team members a robust compensation package that features industry leading pay, no-cost single-payer health coverage, dental/vision/life insurances, 401K (with match), and a growing list of perks to include discounts with major travel and fitness providers. With over 100 team members and a growing list of opportunities, life at Immacu... view company details

II-VI Incorporated develops, manufactures, and markets engineered materials, and optoelectronic components and devices worldwide. The company operates in three segments: II-VI Laser Solutions, II-VI Photonics, and II-VI Performance Products. The II-VI Laser Solutions segment offers optical and electro-optical components and materials primarily used in high-power CO2 lasers; fiber-delivered beam delivery systems, and processing tools and direct diode lasers for industrial lasers; direct diode laser modules, sub-systems, and systems; super-hard materials processing laser systems; and compound se... view company details

Flight display systems manufacture in-flight entertainment products and military surveillance monitors. view company details

The Virginia State Police, officially the Virginia Department of State Police, is a U.S. state law enforcement agency, conceived in 1919 and established in 1932, that acts as the state police force for the Commonwealth of Virginia in the United States. The agency originated out of the Virginia Department of Motor Vehicles as an inspector and enforcer of highway laws. It is currently one of fourteen agencies within the Cabinet Secretariat of Public Safety, under the leadership of Secretary Brian Moran. On January 18, 2018, Gary T. Settle was sworn in as Superintendent of the Virginia State Po... view company details

Aircastle Limited, through its subsidiaries, leases, finances, sells, and manages commercial flight equipment to airlines worldwide. As of December 31, 2018, its aircraft portfolio comprised 261 aircraft leased to 81 lessees located in 44 countries. Aircastle Limited was founded in 2004 and is based in Stamford, Connecticut. view company details

Odyssey Space Research, L.L.C. is a dynamic, small business based in Houston, Texas at NASA's Johnson Space Center (JSC). We provide advanced engineering services in the core domain of Guidance, Navigation & Control (GN&C) design, research and analysis, software, simulation, integration, evaluation and test. We specialize in rendezvous, proximity operations and capture (including automated rendezvous and docking) and other in-space flight phases. We have expertise in crewed and un-crewed spacecraft, encompassing automated and manual flight design with emphasis on safety and mission success. view company details

Space Exploration Technologies Corp., doing business as SpaceX, is a private American aerospace manufacturer and space transportation services company headquartered in Hawthorne, California. It was founded in 2002 by entrepreneur Elon Musk with the goal of reducing space transportation costs and enabling the colonization of Mars. SpaceX has since developed the Falcon launch vehicle family and the Dragon spacecraft family, which both currently deliver payloads into Earth orbit. SpaceX's achievements include the first privately funded liquid-propellant rocket to reach orbit (Falcon 1 in 2008), ... view company details

Triumph Group, Inc. designs, engineers, manufactures, repairs, overhauls, and distributes aerostructures, aircraft components, accessories, subassemblies, and systems worldwide. It operates in three segments: Integrated Systems, Aerospace Structures, and Product Support. The company offers aircraft and engine-mounted accessory drives, thermal control systems and components, cargo hooks, high lift actuations, cockpit control levers, hydraulic systems and components, control system valve bodies, landing gear actuation systems, electronic engine controls, landing gear components and assemblies, e... view company details

TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer and wet age-related macular degeneration (AMD). Its lead product candidate is TRC105, an endoglin antibody, which is in randomized Phase III clinical trial for angiosarcoma; Phase I/II clinical trial for hepatocellular carcinoma; Phase I clinical trial for lung cancer; Phase I/II clinical trial for breast cancer; Phase II clinical trials for prostate cancer; and randomized Phase II clinical trial for wet AMD. The company also develops TRC102, a small molecule t... view company details

Epizyme, Inc., a late-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines for patients with cancer and other diseases primarily in the United States. The company's lead products candidate is tazemetostat, an inhibitor of the EZH2 histone methyltransferase, which is in the Phase II clinical trial for patients with relapsed or refractory non-hodgkin lymphoma (NHL); Phase II clinical trial for relapsed or refractory patients with mesothelioma characterized by BAP1 loss-of-function; and Phase II clinical trial for adults and Phase I clinical trial fo... view company details

AirQuest Aviation is a Fixed Base Operator, (FBO). We are located at the Butler County Airport (KBTP) in Butler,Pennsylvania. We are proud to provide premiere aviation support such as flight training, aircraft rental, aircraft sales, aircharter, aircraft maintenance, fuel sales and a wide variety of concierge services. Our services, however, go beyond our customer's expectations. We are devoted to customer service and commitment in doing whatever it takes to accommodate our client's flights. view company details

At BAE Systems, we help our customers to stay a step ahead when protecting people and national security, critical infrastructure and vital information. We provide some of the world's most advanced, technology-led defence, aerospace and security solutions and employ a skilled workforce of 85,800 people in more than 40 countries. From state of the art cyber threat detection to flight control systems that enable pilots to make better decisions, we never stop innovating to ensure that our customers maintain their advantage. This is a long-term commitment involving significant investments in skills... view company details

PASSUR Aerospace, Inc., a business intelligence company, provides predictive analytics and decision support technology for the aviation industry in the United States and internationally. It offers data aggregation and consolidation, information, decision support, predictive analytics, collaborative solutions, and professional services to airlines, airports, governments, and business aviation companies. The company offers various solutions for traffic flow management, diversion management, flight predictability, surface management, turn time management, connectivity and collaboration, and aviat... view company details

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company's lead products consist of four ophthalmology development programs across three targets, including X-linked retinoschisis that is in Phase I/II clinical trials; X-linked retinitis pigmentosa, which is in Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials for the treatment of inherited retinal diseases, as well as a preclinical program in adrenoleukodystrophy, which i... view company details

Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. The company is developing Zygel, a transdermal cannabidiol gel, which is in Phase II clinical trial for treating children and adolescent patients with developmental and epileptic encephalopathies; is in Phase II/III clinical trial to treat children and adolescent patients with fragile X syndrome; and is in Phase II clinical trial for treating children and adolescent pa... view company details

Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing novel therapies for central nervous system (CNS) disorders in the United States. Its product pipeline includes AXS-05, which is in the Phase III clinical trial for the treatment resistant depression; Phase II/III clinical trials in agitation associated with Alzheimer's disease; and Phase II clinical trial for the treatment of smoking cessation, as well as for major depressive disorder. The company is also developing AXS-07, which is in Phase III clinical trial for the treatment of migraine; AXS-12 that... view company details

Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. Its lead drug candidate is Selinexor(KPT-330), which is in Phase IIb clinical study in treatments of refractory multiple myeloma; Phase Ib/II clinical study in combination with backbone treatments for multiple myeloma patients; Phase III clinical trial in combination with Velcade (bortezomib) and dexamethasone for multiple myeloma patients; Phase IIb cli... view company details

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform. The company's lead product candidate is RGX-314, which is in Phase I/IIa clinical trials for the treatment of wet age-related macular degeneration. It is also developing RGX-121 that is in Phase ... view company details

Capricor Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy, or DMD, and other medical conditions. The company's development stage drug candidates for cardiosphere-derived cells include CAP-1002 that completed phase I/II clinical trial in subjects with DMD; phase I clinical trial for treating heart failure; and phase I/II clinical trial in subjects with myocardial infarction. It is also developing CAP-2003 that is in pre-clinical development ... view company details

Caladrius Biosciences, Inc., a late-stage therapeutics development biopharmaceutical company, develops therapeutic product candidates to address diseases and conditions caused by ischemia. Its product candidates include developmental treatments for cardiovascular diseases, such as CLBS12 that is in Phase II clinical trial for the treatment of critical limb ischemia; CLBS14-CMD, which is in Phase II clinical study to treat coronary microvascular dysfunction; and CLBS14-NORDA that is in Phase III clinical trial for treating no-option refractory disabling angina. The company was formerly known as... view company details